Accéder au contenu
Merck

Therapeutic value of melatonin post-treatment on CCl

Canadian journal of physiology and pharmacology (2015-11-18)
Keywan Mortezaee, Fatemeh Sabbaghziarani, Ameneh Omidi, Ahmad Reza Dehpour, Negar Omidi, Soudabeh Ghasemi, Parichehr Pasbakhsh, Iraj Ragerdi Kashani
PMID26572319
RÉSUMÉ

Melatonin is known for being beneficial in targeting liver diseases. This study aimed to investigate whether melatonin post-treatment is capable of rat carbon tetrachloride (CCl